Does CABOZANTINIB Cause Dyspnoea? 143 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Dyspnoea have been filed in association with CABOZANTINIB. This represents 3.7% of all adverse event reports for CABOZANTINIB.
143
Reports of Dyspnoea with CABOZANTINIB
3.7%
of all CABOZANTINIB reports
40
Deaths
125
Hospitalizations
How Dangerous Is Dyspnoea From CABOZANTINIB?
Of the 143 reports, 40 (28.0%) resulted in death, 125 (87.4%) required hospitalization, and 17 (11.9%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB. However, 143 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB Cause?
Diarrhoea (404)
Fatigue (263)
Malignant neoplasm progression (238)
Nausea (215)
Decreased appetite (191)
Off label use (190)
Hypertension (165)
Pyrexia (162)
Vomiting (157)
Asthenia (153)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which CABOZANTINIB Alternatives Have Lower Dyspnoea Risk?
CABOZANTINIB vs CABOZANTINIB S-MALATE
CABOZANTINIB vs CAFFEINE
CABOZANTINIB vs CALASPARGASE PEGOL
CABOZANTINIB vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB vs CALCIFEDIOL